产品说明书

Racecadotril

Print
Chemical Structure| 81110-73-8 同义名 : Acetorphan
CAS号 : 81110-73-8
货号 : A148453
分子式 : C21H23NO4S
纯度 : 98%
分子量 : 385.477
MDL号 : MFCD00865520
存储条件：

粉末 Keep in dark place,Sealed in dry,Room Temperature

液体 -20°C:3-6个月-80°C:12个月
溶解度 :

DMSO: 105 mg/mL(272.39 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方：
生物活性
靶点

  • Opioid receptor
描述 Racecadotril, via its active metabolite thiorphan, is an inhibitor of the enzyme neutral endopeptidase (NEP, EC 3.4.24.11), thereby increasing exposure to NEP substrates including enkephalins and atrial natriuretic peptide (ANP). Upon oral administration racecadotril is rapidly and effectively converted into the active metabolite thiorphan, which does not cross the blood-brain-barrier[3]. Orally administered Racecadotril (100 mg/kg) shows efficacy in a rat model of castor oil-induced diarrhea[4]. Racecadotril is used in the treatment of acute diarrhoea. It prevents the degradation of endogenous opioids (enkephalins), thereby reducing hypersecretion of water and electrolytes into the intestinal lumen. In well controlled trials, racecadotril had efficacy similar to that of loperamide and was generally as effective as loperamide-oxide. In well controlled trials, racecadotril had efficacy similar to that of loperamide and was generally as effective as loperamide-oxide[5]. Racecadotril is more efficacious than other treatments except for loperamide and has a tolerability similar to placebo and better than loperamide[6].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02125604 Relapsing-Remitting Multiple S... 展开 >>clerosis 收起 << Phase 4 Completed - Germany ... 展开 >> Research Site Augsburg, Germany Research Site Bamburg, Germany Research Site Bayreuth, Germany Research Site Berlin, Germany Research Site Bochum, Germany Research Site Bonn, Germany Research Site Erbach, Germany Research Site Erlangen, Germany Research Site Freiburg, Germany Research Site Hamburg, Germany Research Site Leipzig, Germany Research Site Marburg, Germany Research Site Minden, Germany Research Site Mittweida, Germany Research Site Munchen, Germany Research Site Munster, Germany Research Site Osnabruck, Germany Research Site Potsdam, Germany Research Site Siegen, Germany 收起 <<
NCT03005821 Diarrhea Not Applicable Recruiting September 30, 2019 China, Guangdong ... 展开 >> Dongguan Kanghua Hospital Recruiting Dongguan, Guangdong, China, 523080 Contact: Lingjia Yin, Physician    8613112843921    632608836@qq.com 收起 <<
NCT00940290 - Completed - -
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.59mL

0.52mL

0.26mL

12.97mL

2.59mL

1.30mL

25.94mL

5.19mL

2.59mL
参考文献

[1]Marion Eberlin, Tobias Muck, et al. A Comprehensive Review of the Pharmacodynamics, Pharmacokinetics, and Clinical Effects of the Neutral Endopeptidase Inhibitor Racecadotril. Front Pharmacol. 2012; 3: 93.

[2]Wu HT, Chang CK, et al. Increase of plasma insulin by racecadotril, an inhibitor of enkephalinase, in Wistar rats. Horm Metab Res. 2010 Apr;42(4):261-7.

[3]Eberlin M, Mück T, Michel MC. A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril. Front Pharmacol. 2012 May 30;3:93

[4]Griggs DW, Prinsen MJ, Oliva J, Campbell MA, Arnett SD, Tajfirouz D, Ruminski PG, Yu Y, Bond BR, Ji Y, Neckermann G, Choy RK, de Hostos E, Meyers MJ. Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea. J Pharmacol Exp Ther. 2016 May;357(2):423-31

[5]Matheson AJ, Noble S. Racecadotril. Drugs. 2000 Apr;59(4):829-35; discussion 836-7

[6]Eberlin M, Chen M, Mueck T, Däbritz J. Racecadotril in the treatment of acute diarrhea in children: a systematic, comprehensive review and meta-analysis of randomized controlled trials. BMC Pediatr. 2018 Apr 3;18(1):124